Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 USD | -0.40% | -4.18% | -40.00% |
May. 20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
May. 17 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 19-10-07 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 22-02-28 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Martin Krusin
PRN | Corporate Officer/Principal | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-03-02 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 15-04-30 |
Alastair Riddell
BRD | Director/Board Member | 74 | 15-08-31 |
James Sapirstein
CEO | Chief Executive Officer | 63 | 19-10-07 |
Mary Coelho
BRD | Director/Board Member | 62 | 21-08-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,750,090 | 2,594,361 ( 94.34 %) | 0 | 94.34 % |
Company contact information
First Wave Biopharma, Inc.
777 Yamato Road Suite 502
33431, Boca Raton
+561 589 7020
http://www.firstwavebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.00% | 6.24M | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- ENTO Stock
- Company Entero Therapeutics, Inc.